| For: | Tonini V, Zanni M. Pancreatic cancer in 2025: Have we found a solution? World J Gastroenterol 2025; 31(43): 111433 [PMID: 41358172 DOI: 10.3748/wjg.v31.i43.111433] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i43/111433.htm |
| Number | Citing Articles |
| 1 |
Seher Hekimsoy, Aliye Soylu, Mehmet Bayram, Hafize Uzun, Omur Tabak. Evaluation of Pancreatic Lesions: Comparative Analysis of Endoscopic Ultrasonography, Computed Tomography, and Magnetic Resonance Imaging. Medicina 2026; 62(5) doi: 10.3390/medicina62050982
|
| 2 |
Qamar Abuhassan, Hamzeh J. Al-Ameer, Shahad Mohammed Dhiaa Younis, Jasur Rizaev, Makhfirat Kibriyeva, Rasim M. Salih, Mohamed Adil Jaber. Emerging nanoparticle approaches for early detection and therapeutic targeting of pancreatic cancer. Clinica Chimica Acta 2026; 590 doi: 10.1016/j.cca.2026.121102
|
| 3 |
Jun Yu, Yuan Pan, Yi Chen, Zhihui Shu, Lin Ma, Bin Wu, Jingdong Li, Jianshui Li, Chuan Lan. High SOX17 expression is correlated with favorable prognosis and CD8(+) TILs expression in patients with pancreatic cancer after curative resection. Translational Oncology 2026; 70 doi: 10.1016/j.tranon.2026.102859
|
| 4 |
İlkay Çıtakkul, Yasemin Bakkal Temi, Zehra Aytin, Ece Baydar, Umut Kefeli, Devrim Çabuk, Kazım Uygun. EASIX Score as an Independent Prognostic Marker in De Novo Metastatic Pancreatic Cancer. Medicina 2026; 62(3) doi: 10.3390/medicina62030562
|
| 5 |
Wenjing Ding, Yanchun Fang, Hanmeng Xu, Xinyu Zhang, Chao Li, Yanping Wang, Daoxiang Zhang. VDR Activation Suppresses Pancreatic Cancer Metastasis Through Inhibition of the ERK Signaling Pathway. Cancers 2026; 18(14) doi: 10.3390/cancers18142296
|